Metastatic surgery

In patients with singular metastases, who are primarily diagnosed (primary metastases) or at the time of recurrence after curative therapy (secondary metastases). Depending on the origin of the tumor, surgical metastasectomy can be a useful therapeutic option. This applies especially to renal cell carcinoma and prostate carcinoma. Complex imaging is essential for accurate assessment of tumor burden. In patients with suspected prostate carcinoma metastases, molecular imaging using PSMA-PET/CT is the preferred method. Depending on the type of metastasis (lymph nodes, visceral organs or bones), surgical removal of metastases is performed in interdisciplinary cooperation with our multidisciplinary panel of experts from our Departments of Visceral and Thoracic surgery, Tumor Orthopedics and Neurosurgery. We also offer gamma probe-guided lymph node removal for prostate cancer in selected cases. The so-called PSMA-radioguided surgery uses imaging information obtained from the PSMA-PET/CT. Thorough evaluation on case-by-case basis is crucial in order to determine whether surgery for metastases is potentially beneficial to you. Thus, all eligible patients are discussed in a multidisciplinary tumor board clinic. Our recommendations are then discussed individually (link). Furthermore, surgery for metastases has an important role in metastatic testicular cancer. Depending on initial response to chemotherapy, it may be necessary to remove the remaining metastases. This is likewise done after multidisciplinary collaboration with our Department of Visceral and Thoracic Surgery, Tumor Orthopedics and Neurosurgery.